China: NMPA and the restructuring of the pharmaceutical inspection system

China's pharmaceutical inspection framework has undergone a fundamental transformation since 2019. The cancellation of separate GMP certification, nationwide implementation of the marketing authorisation holder (MAH) system and redistribution of inspection responsibilities...
Your Weekly Life Sciences Digest

Your Weekly Life Sciences Digest

Get an online subscription and you can unlock any article you come across, getting instant emails when our site updates, too.

European Commission authorises Amneal’s omalizumab biosimilar Adcomfo

The European Commission granted marketing authorisation for Adcomfo (omalizumab), a biosimilar referencing Xolair, on 12 November 2026. The product was developed by Kashiv BioSciences in collaboration with Alvotech. The decision followed a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), adopted on 17 September 2026, and expands the product’s regulatory presence in European markets. Adcomfo is a recombinant DNA-derived humanised monoclonal antibody...

Access to Medicine Index 2026: Novartis and GSK lead global pharmaceutical industry rankings

The Access to Medicine Foundation has published the tenth edition of its global Access to Medicine Index, assessing how 20 leading research-based pharmaceutical companies are addressing access to essential medicines, vaccines and diagnostic products in 113 low- and middle-income countries (LMICs). The 2026 assessment covers 84 diseases, conditions and pathogens and evaluates company performance against 29 metrics across three technical areas: Governance of Access, Research & Development (R&D) and...

In ovo immune-complex vaccination protects broilers against heterologous vvIBDV challenge

An in ovo immune-complex vaccine protected broiler chickens against clinical disease, acute bursal lesions and growth impairment following challenge with a heterologous very virulent infectious bursal disease virus (vvIBDV) strain, according to a study published in Vaccines. The study, conducted by researchers from HIPRA S.A., evaluated the efficacy of an immune-complex vaccine containing live attenuated IBDV strain 1052 and egg-derived IgY antibodies. The findings also highlight the importance of distinguishing...

Japan: PMDA and MHLW — who inspects your site, and who decides?

Japan has a distinctive pharmaceutical inspection system in which inspection activities and administrative responsibilities are distributed among the Pharmaceuticals and Medical Devices Agency (PMDA), the Ministry of Health, Labour and Welfare (MHLW), and Japan’s 47 prefectural governments. For foreign pharmaceutical manufacturers, understanding this division is essential. PMDA conducts GMP inspections of overseas manufacturing sites and reports the results to MHLW, while administrative powers are exercised by the competent authority under...

mRNA–LNP vaccine reduces H5N1 viral replication and mammary damage in dairy cows

A nucleoside-modified mRNA vaccine developed by researchers from the University of Pennsylvania and the US Department of Agriculture (USDA) significantly reduced viral replication and disease severity in lactating dairy cows experimentally challenged with highly pathogenic avian influenza (HPAI) H5N1. The vaccine reduced peak viral RNA levels in milk by approximately 1,000-fold and limited mastitis and mammary tissue fibrosis, according to a study published in Nature Biotechnology. The findings provide experimental...

GMP & Guidance

Documents available for download

EU–US GMP mutual recognition becomes fully operational for veterinary medicines

The European Union and the United States have completed the assessment of all EU Member States' competent authorities under the pharmaceutical Good Manufacturing Practice (GMP) Mutual Recognition Agreement (MRA)...

UAE EDE introduces new regulatory controls for peptide products and molecules

Read the official EDE Circular No. 46/2026 and download the full regulatory document in the TOP-Pharma Resource Centre. The Emirates Drug Establishment (EDE) has introduced a comprehensive regulatory framework for...

FDA updates its human drug facility inspection framework under ConOps 2.0

The US Food and Drug Administration (FDA) has updated its operating framework for evaluating and inspecting human drug manufacturing facilities. The revised Concept of Operations (ConOps), dated 21 October...

FDA proposes framework for individualized gene therapies as CMS expands access

The US Food and Drug Administration (FDA) has proposed a regulatory framework for individualized human genome editing therapies, while the Centers for Medicare & Medicaid Services (CMS) plans to...
spot_img

Professional Interpreters for
GMP Inspections

Clear Communication for Your GMP Inspection.
We provide expert on-site interpreters who understand pharmaceutical terminology to ensure smooth communication with the inspectors.